Lindbrook Capital’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.44K | Buy |
3,729
+3,720
| +41,333% | +$5.43K | ﹤0.01% | 1917 |
|
|
2024
Q4 | $19 | Buy |
+9
| New | +$19 | ﹤0.01% | 2763 |
|
|
2024
Q3 | – | Sell |
-117
| Closed | -$273 | – | 2825 |
|
|
2024
Q2 | $273 | Sell |
117
-1,132
| -91% | -$2.64K | ﹤0.01% | 2685 |
|
|
2024
Q1 | $5.58K | Sell |
1,249
-348
| -22% | -$1.56K | ﹤0.01% | 1849 |
|
|
2023
Q4 | $5.13K | Buy |
1,597
+949
| +146% | +$3.05K | ﹤0.01% | 1872 |
|
|
2023
Q3 | $2.05K | Sell |
648
-725
| -53% | -$2.3K | ﹤0.01% | 2118 |
|
|
2023
Q2 | $6.82K | Sell |
1,373
-354
| -20% | -$1.76K | ﹤0.01% | 1660 |
|
|
2023
Q1 | $8.53K | Buy |
+1,727
| New | +$8.53K | ﹤0.01% | 1550 |
|
|
2022
Q4 | – | Sell |
-418
| Closed | -$5K | – | 2830 |
|
|
2022
Q3 | $5K | Sell |
418
-18
| -4% | -$215 | ﹤0.01% | 1630 |
|
|
2022
Q2 | $5K | Buy |
436
+326
| +296% | +$3.74K | ﹤0.01% | 1518 |
|
|
2022
Q1 | $1K | Buy |
+110
| New | +$1K | ﹤0.01% | 2150 |
|